Green light for the super-technological center, will be among the most advanced in the world.
One year for the works to begin, four years until fully operational.
Now that the construction contract has been signed, the project, promoted by Medipass, has reached the implementation stage. It is one of the greatest medical tech projects ever launched in Italy. Proton therapy is considered particularly effective in cancer treatment, and has been adopted by some of the most prestigious medical institutions in the world.
Advantages over photon therapy, patients from all over Italy.
Treatment for advanced cancer: the contract is signed. It will cost 159 million euros.
The radiopharmacy unit at Castelfranco Veneto Hospital has now been ready for two years, to comply with new regulations. Since July 1st it distributes radiopharmaceuticals in Treviso, Mestre and Vicenza, thus making Veneto self-sufficient in the manufacturing of radiopharmaceuticals.
Public-private partnership as a tool for the delivery of high-tech therapeutic services with clear deadlines and a guaranteed expansion of the service offer to patients.
State-of-the-art integrated services boost the range of diagnostic services provided.
Risk management as a key factor for the optimal quality and safety management.
Risk management as a key factor for optimal quality and safety management.